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Abstract
Background: Health expenditure for tuberculosis (TB) care often pushes households into catastrophe and poverty.
New Cooperative Medical Scheme (NCMS) aims to protect households from catastrophic health expenditure (CHE)
and impoverishment in rural China. This article assesses the effect of NCMS on relieving CHE and impoverishment
from TB care in rural China.
Methods: Three hundred fourty-seven TB cases are included in the analysis. We analyze the incidence and intensity
of CHE and poverty, and assess the protective effect of NCMS by comparing the CHE and impoverishment before
and after reimbursement.
Results: After out-of-pocket (OOP) payment for TB care, 16.1 % of non-poor fall below poverty line. The NCMS
reduces the incidence of CHE and impoverishment by 11.5 % and 7.3 %. After reimbursement, 46.7 % of the
households still experience CHE and 35.4 % are below the poverty line. The NCMS relieves the mean gap, mean
positive gap, poverty gap and normalized positive gap by 44.5 %, 51.0 %, US$115.8 and 31.6 % respectively.
Conclusions: The NCMS has partial effect on protecting households from CHE and impoverishment from TB care.
The limited protection could be enhanced by redesigning benefit coverage to improve the “height” of the NCMS
and representing fee-for-service with alternative payment mechanisms.
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Background
China ranks second on the list of countries with the largest
burden of tuberculosis (TB) in the world [1]. TB is often
regarded as “a disease of the poor” [2, 3]. There is an obvi-
ous vicious circle between TB and poverty. On the one
hand, the poor are at a high risk of TB infection and have
higher TB prevalence and incidence [3–7]. On the other
hand, TB contributes much to poverty by affecting nega-
tively the labor supply which would result in a severe loss of
future earning for patients’ families [3, 8–10]. Furthermore,
many studies have documented that TB patients incur high
costs for diagnosis and treatment despite TB care offered
for free in most settings, and households often have to bor-
row money or sell assets to pay for TB care, which places
the patients’ households at higher risk of catastrophic health
expenditure (CHE) and pushes them into poverty [11–13].
Health insurance has been seen as an effective way to
reduce economic burdens of illness and protect households
from CHE and impoverishment [14–16]. In China, health
insurance system consists of three separate schemes,
among which New Cooperative Medical Scheme (NCMS)
is most an important scheme for rural residents. The
NCMS, started in 2003, is a voluntary program based on a
joint funding from the central, provincial, county level
governments and also enrollees premium [17–20]. The
central government is responsible for the scheme manage-
ment and supervision, while the scheme implementation
responsibilities are decentralized to local governments. By
the end of 2011, NCMS had covered about 832 million
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rural population in China, and the coverage had increased
to 97.5 %. Meanwhile, the NCMS revenues per capita in-
creased to 250 RMB (39.8 US$)1 in 2011 [21].
The primary objective of the Chinese health insurance
schemes is to prevent the population from impoverishing
for health expenditures. Some studies have documented
that health insurance can protect patients from CHE, al-
though in some countries the effect is partial or limited
[15, 22–24]. There is, however, no studies reporting the
health insurance effect on CHE and impoverishment for
TB care. To evaluate the health insurance impact on cata-
strophic health expenditure and impoverishment for TB, a
disease strongly associated with poverty, is of high priority.
This study aims to analyze the incidence and intensity of
CHE and impoverishment for TB care, assess the effect of
NCMS, and also governmental and other subsidies on
CHE and impoverishment, so as to provide policy implica-
tions for NCMS and governmental subsidy in preventing
CHE and impoverishment from TB care.
Methods
Study participants
The present study uses the data of the baseline survey of
the Gates Foundation Phase II program. The baseline sur-
vey is conducted in Zhenjiang City of Jiangsu Province;
Yichang City of Hubei Province and Hanzhong City of
Shaanxi Province. Three counties or districts (one from
each category of high, middle and low GDP per capita) are
selected as study sites in each city (Dantu, Yangzhong
and Jurong in Zhenjiang; Zhijiang, Yidu and Wufeng in
Yichang; and Chenggu, Mian and Zhenba in Hanzhong).
The NCMS coverage rates in all of the study sites were
over 95 % by the end of 2011, which were similar with that
at the national level. The NCMS offices of the study sites
are responsible for qualifying who and how much the
NCMS would cover.
In the selected study sites, TB cases are diagnosed and
treated in local TB dispensaries (LTD) or designated hospi-
tals, which are also similar with that elsewhere. Those lower
levels of providers, such as township health centers and
clinics, cannot diagnose and treat the TB cases, but only to
detect the cases as suspicious patients and then referred to
the LTD or designated hospitals. All diagnosed TB cases
(including new and relapsed patients) are required to be
registered in the local dispensaries and reported to upper
level health authorities. The participants of this study are
selected by using a two-stage cluster random sampling
method. In the first stage, three townships/streets are ran-
domly selected in each sampling county/district. In the
second stage, about 30 TB cases are randomly selected
from the list of registered cases in each township/street.
The participants could be new cases or retreated cases,
but should meet the criteria that they had completed
the normal treatment or stop treatment during 2012. A
total of 347 cases with complete data and covered by
the NCMS are included in the analysis.
Data collection
A standardized questionnaire is used for the survey. The
questionnaire includes a detailed list of the total expenses
before reimbursement, the NCMS reimbursement for TB
care, out-of-pocket (OOP), medical and non-medical costs
incurred in the pathways to TB diagnosis and treatment,
household income, household expenditure, subsidies from
government and others. Furthermore, demographic and
socio-economic information of patients and their house-
holds are also included, such as age, sex, education, and
marital status.
In this study, OOP payments and total health expend-
iture on TB care were collected by the TB patients per in-
dividual. If the family has more than one TB patients, we
will obtain the sum of OOP payments and health expend-
iture on TB care of all TB patients in the same family as a
whole. The household expenditure, food expenditure, and
capacity to pay were collected by houses, not individuals.
The patient survey was conducted by university/college
students from Huazhong University of Science and Tech-
nology (Yichang), Xi’an Jiaotong University (Hanzhong)
and Nanjing Medical University (Zhenjiang). The tech-
nical assistance team (TA) from Duke Global Health Insti-
tute, US, Sussex University, UK, and Shandong University,
China also took part in the baseline survey. The inter-
viewers had received an appropriate training on interview
skills and the contents of the questionnaire before the sur-
vey. All the patients were interviewed in local TB dispens-
aries, designated hospitals or in local township health
centers during April to May in 2013.
Definitions
CHE is usually assessed by incidence and intensity. Head
count (HC) is used to measure incidence, mean gap (MG)
and mean positive gap (MPG) are used to reflect intensity.
HC means the percentage of households whose OOP pay-
ments as a proportion of income, equals or exceeds a
threshold. There is no consensus on the thresholds, but
the two most commonly used are: 10 % of total household
income, and 40 % of household capacity to pay. In this
study, we empirically use the latter to measure CHE. That
is to say, the total OOP payments equaling or exceeding
40 % of the household capacity to pay is regarded as cata-






Where N is the sample size, E is an indicator equal to 1
if OOP of a household i as a proportion of its capacity to
pay is greater than the threshold Z and zero otherwise.
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MG is the average amount by which payments, as a pro-
portion of income, equal or exceed 40 % of their non-food






Where N is the sample size, G is an indication of how
much OOP exceed the threshold, equal to Ti/Xi-Z if Ti/
X > Z and zero otherwise. Here, Ti is the OOP payments
of household i, Xi is the household capacity to pay and
Z is the threshold share. MPG is defined as the head
count being a fraction of the MG.
The national poverty line of Chinese RMB 2300 Yuan
(366.2 US$) per person per year (equal to international pov-
erty line of US$ 1 Yuan per day, a currency exchange rate
of Chinese RMB 628 Yuan to US$100 Yuan at the end of
2012) is used to estimate poverty levels before and after
reimbursement. This poverty line was defined by China
government in 2011, and could provide a criterion for com-
parisons before and after NCMS reimbursement for TB
care. Similar to the measurement of CHE, four indicators
are presented to measure poverty. Similar with CHE, pov-
erty is also assessed by incidence and intensity. Poverty
head count is used to measure incidence, poverty gap (PG),
normalized poverty gap (NPG), and mean positive poverty
gap (MPPG) are used to reflect intensity. Poverty head
count means the proportion of households living below the
poverty line. PG is defined as average of all shortfalls from
the poverty line. NPG is obtained by dividing the poverty
gap by the poverty line. MPPG is defined as the poverty
head count being a fraction of the poverty gap [25, 26]. The
estimation methods of the four indicators of poverty are
similar with those of CHE. Adam Wagstaff and Eddy van
Doorslaer have reported the methodology in detail [26].
OOP payments for TB care in this study include direct
health expenditures on diagnosis and treatment (consult-
ation fees, laboratory tests, X-rays, drugs, and hospital care),
associated transport and accommodation costs for patients
and companions, nutrition supplements cost and others.
Insurance costs are not included in the OOP payments and
health expenditures.
Social demographic characteristics include gender, age,
type of TB cases, education, and marital status. The age of
the participants is grouped into three types: ≤40, 41–59 and
≥60 years. Other demographic characteristics are catego-
rized as follows: gender (male vs. female), type of TB cases
(new vs. relapse), education (none, primary school, jun-
ior school and senior school or above), and marital sta-
tus (married, single and bereft of spouse).
Data analysis
The data is double entered and checked using EPI Data
6.04. SPSS 13.0 is used to analyze the data. Expenses
including total expenditure on TB care, OOP, household
income, and capacity to pay are presented as means and
standard deviation. Head count is described as proportion.
To evaluate the effect of NCMS and governmental subsid-
ies on CHE and impoverishment, three scenarios are con-
sidered: (i) before reimbursement; (ii) after reimbursement
from NCMS; and (iii) after reimbursement from NCMS
and subsidies from the government and other sources.
The difference is obtained between before and after reim-
bursement from NCMS, and also subsidies.
Results
The mean age is 54.1 years (SD = 14.4 years) with a me-
dian of 57.0 years (15 to 86 years). Of the participants,
74.9 % males and 25.1 % females; 19.0 % never educated,
32.6 % primary education, 36.9 % junior education, and
11.5 % senior education and above. With regard to the
patients, 83.0 % are new cases or never treated, while
17.0 % are relapsed or previously treated. As for marital
status, 81.8 % married, 4.6 % single, and 13.5 % bereft of
spouse (see Table 1).
The direct health expenditure for TB care is the most
important component of the OOP, accounting for over
Table 1 Socio-demographic characteristics of the participants


















Primary school 113 32.6
Junior school 128 36.9




Bereft of spouse 47 13.5
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72 % of the total OOP payments, followed by transport
and accommodation costs for patients and companions
(13.3 %), and nutrition supplements cost (13.1 %). We pre-
sented the details of the components of OOP payments in
Additional file 1: Table S1, and interested readers are en-
couraged to refer to that table.
Table 2 shows that 58.2 % of patients experience CHE
before reimbursement for TB care. After reimbursement,
the CHE head count falls to 46.7 %. When taking the sub-
sidies into account, we find that there is a further decrease
of head count in Zhenjiang (2.6 %) and Hanzhong (0.6 %)
after subsidies from government and other sources. Table 3
shows the NCMS effect on intensity of CHE. Before reim-
bursement, the MG and MPG are 97.4 and 186.8 %. After
reimbursement, the MG and MPG fall to 52.9 and 135.8 %
respectively and further to 49.8 and 130.0 % after subsidies.
Without considering OOP payments for TB care, poor
households (below the poverty line) account for 19.3 %
of all households and over 97.0 % of the households are
in the poorest quintile (Q1). After OOP payments for
TB care, we find 16.1 % of non-poor households become
poor. Impoverishment from TB care is more common in
the poorer quintiles (Q1, Q2) (Table 4).
Before reimbursement, households below poverty line
account for 42.7 %. The NCMS reduces the headcount
rate by 7.3 % and the before and after difference is highest
in Hanzhong (9.0 %). But the subsidies have no effect on
decreasing impoverishment (Table 5). Table 6 shows the
NCMS on intensity of impoverishment. The NCMS de-
creases the PG, NG and MPPG by 115.8 US$, 31.6 %, and
183.3 US$ respectively. However, the subsidies only have a
very small impact on the three above-mentioned indica-
tors, which are 7.4 US$, 2.0 %, and 20.9 US$ respectively.
Discussion
The participants of this study are NCMS enrollees.
Those who are not covered by the scheme or who can-
not afford the deductible are not included in our study,
which would probably lead to an underestimation of in-
cidence and intensity of CHE and impoverishment. We
collect the data mainly by self-reported investigations.
Data on household income, food consumption, expenses
on TB care and NCMS claims are probably inaccurate for
interviewees’ recall bias or their unwillingness to tell the
truth. Due to the limitations of cross-sectional study de-
sign, we mainly use some descriptive indicators to evaluate
the effect, and we cannot interpret the findings as cause
and effect. In addition, the sample size of this study is a
little small, which might affect the statistical power to some
extent. Despite these limitations, the findings of this study
would offer an insight into the effect of NCMS and
Table 2 NCMSa impact on incidence of catastrophic expenditure for TB care, China, 2012
Indicators Study locations All
Hanzhong Yichang Zhenjiang
Average capacity to pay (US$) (A1) 2436.6 (1781.0)b 3242.8 (2245.4) 5143.7 (3219.3) 3042.9 (2268.5)
Average food expenditure (US$) (A2) 958.0 (444.8) 1157.5 (501.9) 1906.7 (708.4) 1139.4 (530.1)
Ratios of A2 versus A1 1 : 2.54 1 : 2.80 1 : 2.70 1 : 2.67
Total expenditure on TB care (US$c) 1696.6 (1201.1) 1257.7 (911.4) 2226.9 (904.4) 1591.8 (1074.4)
OOPd payments for TB care (US$) 1094.1 (900.5) 898.9 (736.5) 1592.8 (649.5) 1077.0 (817.4)
OOP payments share of total expenditure on TB care (%) 64.5 71.5 71.5 67.7
Reimbursement from health insurance system (US$) 589.2 304.6 619.0 485.9
NCMS share of total expenditure on TB care (%) 34.7 24.2 27.8 30.5
Subsidies from government and other sources (US$) 13.4 54.25 15.1 28.9
Subsidy share of total expenditure on TB care (%) 0.8 4.3 0.7 1.8
Households with catastrophic expenditure (%)
Before reimbursement (CB) 63.5 50.8 59.0 58.2
After reimbursement (CA) 51.1 39.2 51.3 46.7
After reimbursement and subsidies (CS) 50.6 39.2 48.7 46.1
Difference (%)
CB-CA 12.4 11.6 7.7 11.5
CA-CS 0.6 0.0 2.6 0.6
CB-CA-CS 13.0 11.6 10.3 12.1
aNCMS means New Cooperative Medical Scheme, the same below;
bMean (SD)
cA currency exchange rate of Chinese RMB 628 Yuan to US$1 00 Yuan (at the end of 2012);
dOOP : out-of-pocket
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governmental subsidy on protection from CHE and impov-
erishment for TB care.
We find that TB places a really heavy financial burden
on those sufferings. The health expenditure for TB care be-
fore reimbursement accounts, in average, for 52.3 % of the
annual household capacity to pay. It is much higher than
what is reported for chronic disease in Shandong (27 %)
and Ningxia (35 %) [22]. The proportion of households
whose total expenditure on TB care equals or exceeds 40 %
of non-food income is 58.2 % before reimbursement, which
is also much higher than the reported for chronic disease
in Shandong and Ningxia (varied from 14–21 %). The
OOP payments for TB care account for about an average
of 35.4 % of the annual household non-food income, which
is a little higher than that for TB care in Nigeria (29.1 %)
[27], and also much higher than those reported in other
countries [16].
The study shows that TB has a significant impoverishing
effect in rural China. A study of 11 Asian countries survey
showed that the OOP payments for healthcare raised the
poverty head count by 2.7 % at the international line [28].
In China, a study conducted in 1998 found that OOP pay-
ments for healthcare added the rate from 3.26 to 7.22 % at
the Chinese official poverty line [29]. A study using the
data from 2000 Chinese National Bureau of Statistics
showed that OOP payments for healthcare increased the
poverty rate by 2.6 % at the poverty line of US $1.08 per
day [28]. Another study using the data of the China
Fourth National Health Service Survey (2008) indicated
that the OOP payments pushed 7.0 % of non-poor into
the poor at the poverty line of US$ 449.40 per year [30].
The impoverishment from OOP for TB care of our study
(16.1 %) is much higher than that of the above studies.
Similar to previous study, we also find that impoverish-
ment is more common in poorer TB patients [30].
Our findings show that the NCMS provide some finan-
cial protection for TB patients. We also find that there is a
certain reduction in intensity indicators including MG,
MPG, PG, NPG and MPPG. This finding is consistent
with other studies conducted in Anhui, Chongqing, Qing-
hai, Shandong and Ningxia of China, and in Gujarat of
India for health expenditure on other diseases [22, 23, 31].
However, this protection is only limited and the expenses
for TB care after reimbursement still pose a threat to some
households. Our study finds that 46.7 % of the households
still experience CHE and 35.4 % are still below the poverty
line even after reimbursement. It implies that there is a big
gap between actual protection level and the ideal goal of
the policy design for the NCMS. Over the last decade,
China has made great strides in NCMS coverage [21]. But
we still need to try to achieve the goal of universal coverage.
Table 3 NCMS impact on intensity of catastrophic expenditure for TB care, China, 2012
Indicators Study locations All
Hanzhong Yichang Zhenjiang
Mean Catastrophic Payment Gap (%)
Before reimbursement (MGB) 155.2 51.7 85.4 97.4
After reimbursement (MGA) 68.6 35.5 43.0 52.9
After reimbursement and subsidies (MGS) 65.6 31.3 42.7 49.8
Mean positive gap (%)
Before reimbursement (MPGB) 237.7 115.4 153.7 186.8
After reimbursement (MPGA) 161.8 105.6 91.0 135.8
After reimbursement and subsidies (MPGS) 157.3 98.2 90.5 130.0
Difference (%)
MGB-MGA 86.6 16.2 42.4 44.5
MGA-MGS 3.0 4.2 0.3 3.1
MPGB-MPGA 75.9 9.8 62.7 51.0
MPGA-MPGS 4.5 7.4 0.5 5.8
Table 4 Headcounts of prepayment poverty and of poverty
impoverished by TB OOP expenses, China, 2012
Characteristic Hpre (%) Hoop (%) Impoverished (%)
Study locations
Hanzhong 26.4 44.4 18.0
Yichang 12.3 26.2 13.1
Zhenjiang 10.3 25.6 15.3
Household income quintilesa
Q1 60.6 84.4 13.8
Q2 1.8 29.8 28.0
Q3 0.0 12.3 12.3
Q4 0.0 4.0 4.0
Total 19.3 35.4 16.1
aQuartile1 (Q1) is the poorest and Quartile 4 (Q4) is the richest
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Table 5 NCMS impact on incidence of impoverishment for TB care, China, 2012
Indicators Study locations All
Hanzhong Yichang Zhenjiang
Poverty line (US$a) 366.2 366.2 366.2 366.2
Poverty headcounts (%)
Before reimbursement (PB) 53.4 31.5 30.8 42.7
After reimbursement (PA) 44.4 26.2 25.6 35.4
After reimbursement and subsidies (PS) 44.4 26.2 25.6 35.4
Difference (%)
PB-PA 9.0 5.3 5.2 7.3
PA-PS 0.0 0.0 0.0 0.0
aA currency exchange rate of Chinese RMB 628 Yuan to US$1 00 Yuan (at the end of 2012)
Table 6 NCMS impact on intensity of impoverishment for TB care, China, 2012
Indicators Study locations All
Hanzhong Yichang Zhenjiang
Poverty gap (US$a)
Pre-payment (PGpre) 45.2 14.0 8.6 26.0
Before reimbursement (PGB) 465.6 188.8 237.4 297.7
After reimbursement (PGA) 285.9 118.9 126.7 181.9
After reimbursement and subsidies (PGS) 280.1 106.6 120.6 174.5
Difference (US$)
PGB-PGA 179.7 69.9 110.7 115.8
PGA-PGS 5.8 12.3 6.1 7.4
PGB-PGpre 420.4 164.8 228.8 271.7
PGS-PGpre 234.9 92.6 112.0 148.5
Normalized poverty gap (%)
Pre-payment (NPGpre) 12.3 3.8 2.3 7.1
Before reimbursement (NPGB) 127.1 51.6 64.8 81.3
After reimbursement (NPGA) 78.1 32.5 34.6 49.7
After reimbursement and subsidies (NPGS) 76.5 29.1 32.9 47.7
Difference (%)
NPGB-NPGA 49.1 19.1 30.2 31.6
NPGA-NPGS 1.6 3.4 1.7 2.0
NPGB-NPGpre 114.8 47.7 62.5 74.2
NPGS-NPGpre 64.1 25.3 30.6 40.6
Mean positive poverty gap (US$)
Pre-payment (MPPGpre) 171.2 113.8 83.5 134.7
Before reimbursement (MPPGB) 871.9 599.4 770.8 697.2
After reimbursement (MPPGA) 643.9 453.8 494.9 513.8
After reimbursement and subsidies (MPPGS) 630.9 406.9 471.1 492.9
Difference (US$)
MPPGB-MPPGA 228.0 145.5 275.9 183.3
MPPGA-MPPGS 13.1 46.9 23.8 20.9
MPPGB-MPPGpre 700.7 485.5 687.3 562.5
MPPGS-MPPGpre 459.6 293.0 387.6 358.2
aA currency exchange rate of Chinese RMB 628 Yuan to US$1 00 Yuan (at the end of 2012)
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The universal coverage policy declared by WHO includes
three dimensions: breadth, depth and height [30, 32]. In this
study, the ‘height of coverage’ of NCMS, which refers to
the extent to which health service costs are covered, is rela-
tively low and insufficient to reach the goal of the universal
coverage. This poor ‘height of coverage’ of NCMS for TB
care is mainly due to two aspects of reasons. One is the po-
tential shortcomings of the policy design for NCMS, and
the other is the high cost for TB care.
In China, the government commits to provide free diag-
nosis and treatment for TB cases. However, the providers,
under a circumstance of FFS system, still have strong in-
centives to prescribe expensive medical examinations and
new drugs beyond the free service package recommended
by the national TB program [30, 33]. Previous studies in-
dicated that the doctors recommend liver protection and
ancillary drugs, follow-up X-rays even CT tests and blood
tests which would add to OOP payments [11, 34, 35]. This
supplier-induced demand on a FFS basis has contributed
to a rapid increase in TB care costs. In order to effectively
contain costs on TB-related healthcare, this project will
carry out an intervention of case-based payment model in
the further study, and will examine the impact of the new
payment model on CHE and impoverishment.
Our results indicate that subsidies from the government
and other sources (mainly refers to Medical Financial As-
sistance, MFA) have little effect on the protection against
CHE and impoverishment. There are two explanations for
the relatively little effect in our study. First, the amount of
subsidies from the government and other sources are rela-
tively small. When compared with the large amount of total
expenditure for TB care, the effect of subsidies on financial
protection is greatly undermined. Second, the limited finan-
cial assistance fund might be used mainly to increase the
“breadth” rather than to improve the “height”. Therefore,
TB control program should address the medical subsidies
to maximize its efficiency by expanding the subsidy sources
and assisting the most really vulnerable patients so as to
improve the “height”.
Conclusion
This study finds that NCMS has partial effect on protect-
ing households from CHE and impoverishment from TB
care, and governmental and other subsidies have little ef-
fect on this protection. Our findings present four import-
ant implications for health policymakers. First, TB places a
really heavy financial burden on households suffered from
TB in China. It is vital to develop TB-targeting policies to
protect against financial risk, such as establishing special
fund for TB or bringing TB (for those poor sufferings) into
the package of the most serious diseases affecting Chinese
population. Second, the impoverishment from TB care is
more common in poorer households. There is a need to
develop pro-poor interventions. A mix of health insurance
schemes and MFA for the poor might be useful for provid-
ing a financial protection. Third, the NCMS aims to pro-
tect enrollees against CHE and impoverishment, but this
aim is only partly achieved due to the high costs for TB
care and poor ‘height of coverage’. It suggests for decision
makers to develop comprehensive strategies to address
the problem. This might be achieved through redesigning
benefit coverage to improve the “height” of the NCMS,
representing FFS with alternative payment mechanisms
such as case-based payment and extending broadly the TB
free service package. Finally, the subsidies from govern-
ment and other sources have little effect on financial pro-
tection against CHE and impoverishment. It implicates for
policymakers to improve the subsidy height by assisting
those who were really catastrophic.
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